Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
The Michael J. Fox Foundation, NIH, and five life sciences companies—Celgene, GlaxoSmithKline, Pfizer, Sanofi, and Verily Life Sciences—have launched a public-private partnership aimed at understanding the molecular underpinnings of Parkinson’s disease. The partners have jointly committed $24 million to the project, which is part of NIH’s Accelerating Medicines Partnership. The first goal of the partnership is to analyze existing data and patient samples for biomarkers that allow the disease to be measured, tracked, and ultimately, treated.
This article has been sent to the following recipient: